IDO1 and malignant colon neoplasm: IDO1 overexpression is also observed in colon cancer cell lines (HCT-116 and HT-29) in absence of an inflammatory environment, suggesting that genetic mutations or epigenetic modification of IDO1 could also be driving colon carcinogenesis [32,163,164].